Table 9.12b

Adjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 625 96.3% 0.8% 625 92.1% 1.2% 1,487 83.1% 1.1% 2,108 76.9% 1.1%
Primary Diagnosis Non-Cholestatic Cirrhosis 308 95.9% 1.1% 308 91.4% 1.7% 778 81.4% 1.6% 1,047 74.1% 1.7%
Cholestatic Liver Disease/Cirrhosis 137 96.7% 1.5% 137 95.4% 1.8% 287 94.3% 1.5% 376 84.3% 2.8%
Acute Hepatic Necrosis 28 95.7% 4.2% 28 91.3% 5.8% 66 72.8% 6.1% 106 71.7% 4.4%
Biliary Atresia 58 + + 58 + + 136 87.5% 4.0% 232 87.6% 2.3%
Metabolic Diseases 14 78.3% 11.0% 14 63.8% 12.7% 38 66.1% 8.1% 66 75.2% 5.4%
Malignant Neoplasms 31 100.0% 0.0% 31 80.8% 7.0% 78 63.1% 6.2% 131 53.6% 5.2%
Other 49 95.8% 2.9% 49 91.6% 4.0% 104 84.4% 4.0% 150 83.9% 3.1%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.